• Home
  • About Us
  • Clinical trials
  • News
  • Contacts
+7 (495)105 99 05 crd@ollamed.ru
  • Русский (Россия)
  • English (United Kingdom)
Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО
  • Home
  • About Us
  • Clinical trials
  • News
  • Contacts
Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО
  • Home
  • About Us
  • Clinical trials
  • News
  • Contacts

News

  • Home /
  • News /
  • Trials /
  • Approval from Salix Research

Approval from Salix Research

Super User
Trials
Read Time: 1 min
Created: 06 December 2021
Hits: 0

Successfully passed the visit of the selection center to participate in the study of a new medicine for the treatment of ulcerative colitis, the sponsor of the study is the pharmaceutical company Salix Pharmaceuticals

Search

Sections

  • Progress

  • Trials

  • Information

Last news

  • Completion of the study 25 Jun 2025
  • Evaluation of the possibility of conducting clinical trials of vaccines for the prevention of meningococcal and pneumococcal infections in the pediatric population. 06 May 2025
  • The visit of the selection center to participate in two studies of biological drugs for the treatment of IBD has been successfully completed. 08 Apr 2025

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen
Contact US
  • 8 (800) 444 06 68
  • ctd@ollamed.ru
  • 8А, 9-ya Parkovaya st., Moscow, Russia
  • Working time: 9:00-18:00 Mo-Fr

News

  • Completion of the study 25 Jun 2025
  • Evaluation of the possibility of conducting clinical trials of vaccines for the prevention of meningococcal and pneumococcal infections in the pediatric population. 06 May 2025
  • The visit of the selection center to participate in two studies of biological drugs for the treatment of IBD has been successfully completed. 08 Apr 2025
Copyright © 2026 Clinical trials department LLC "OLLA-MED"